FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013150218> ?p ?o ?g. }

• W2013150218 endingPage "4780" @default.
• W2013150218 startingPage "4768" @default.
• W2013150218 abstract "An enlarged series of pyrazolotriazolopyrimidines previously reported, in preliminary form (Baraldi et al. J. Med. Chem. 1999, 42, 4473-4478), as highly potent and selective human A(3) adenosine receptor antagonists is described. The synthesized compounds showed A(3) adenosine receptor affinity in the sub-nanomolar range and high levels of selectivity evaluated in radioligand binding assays at human A(1), A(2A), A(2B), and A(3) adenosine receptors. In particular, the effect of the chain at the N(8) pyrazole nitrogen was analyzed. This study allowed us to identify the derivative with the methyl group at the N(8) pyrazole combined with the 4-methoxyphenylcarbamoyl moiety at the N(5) position as the compound with the best binding profile in terms of both affinity and selectivity (hA(3) = 0.2 nM, hA(1)/hA(3) = 5485, hA(2A)/hA(3) = 6950, hA(2B)/hA(3) = 1305). All the compounds proved to be full antagonists in a specific functional model where the inhibition of cAMP generation by IB-MECA was measured in membranes of CHO cells stably transfected with the human A(3) receptor. The new compounds are among the most potent and selective A(3) antagonists so far described. The derivatives with higher affinity at human A(3) adenosine receptors proved to be antagonists, in the cAMP assay, capable of inhibiting the effect of IB-MECA with IC(50) values in the nanomolar range, with a trend strictly similar to that observed in the binding assay. Also a molecular modeling study was carried out, with the aim to identify possible pharmacophore maps. In fact, a sterically controlled structure-activity relationship was found for the N(8) pyrazole substituted derivatives, showing a correlation between the calculated molecular volume of pyrazolo[4,3-e]1,2, 4-triazolo[1,5-c]pyrimidine derivatives and their experimental K(i) values." @default.
• W2013150218 created "2016-06-24" @default.
• W2013150218 creator A5007536978 @default.
• W2013150218 creator A5008583952 @default.
• W2013150218 creator A5013716423 @default.
• W2013150218 creator A5014165482 @default.
• W2013150218 creator A5018360276 @default.
• W2013150218 creator A5020435407 @default.
• W2013150218 creator A5026868070 @default.
• W2013150218 creator A5027485003 @default.
• W2013150218 creator A5041567500 @default.
• W2013150218 creator A5063804577 @default.
• W2013150218 creator A5070019673 @default.
• W2013150218 date "2000-11-21" @default.
• W2013150218 modified "2023-10-15" @default.
• W2013150218 title "Pyrazolo[4,3-<i>e</i>]1,2,4-triazolo[1,5-<i>c</i>]pyrimidine Derivatives as Highly Potent and Selective Human A₃Adenosine Receptor Antagonists: Influence of the Chain at the N⁸Pyrazole Nitrogen" @default.
• W2013150218 cites W1545295983 @default.
• W2013150218 cites W1966657000 @default.
• W2013150218 cites W1977365273 @default.
• W2013150218 cites W1979611230 @default.
• W2013150218 cites W2002112161 @default.
• W2013150218 cites W2010310682 @default.
• W2013150218 cites W2015480020 @default.
• W2013150218 cites W2042155103 @default.
• W2013150218 cites W2044257233 @default.
• W2013150218 cites W2054906104 @default.
• W2013150218 cites W2069775060 @default.
• W2013150218 cites W2069812375 @default.
• W2013150218 cites W2080170127 @default.
• W2013150218 cites W2082370179 @default.
• W2013150218 cites W2137772461 @default.
• W2013150218 cites W2156032902 @default.
• W2013150218 cites W2169920833 @default.
• W2013150218 cites W2492580380 @default.
• W2013150218 cites W4293247451 @default.
• W2013150218 doi "https://doi.org/10.1021/jm001047y" @default.
• W2013150218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11123985" @default.
• W2013150218 hasPublicationYear "2000" @default.
• W2013150218 type Work @default.
• W2013150218 sameAs 2013150218 @default.
• W2013150218 citedByCount "70" @default.
• W2013150218 countsByYear W20131502182012 @default.
• W2013150218 countsByYear W20131502182013 @default.
• W2013150218 countsByYear W20131502182014 @default.
• W2013150218 countsByYear W20131502182015 @default.
• W2013150218 countsByYear W20131502182016 @default.
• W2013150218 countsByYear W20131502182017 @default.
• W2013150218 countsByYear W20131502182018 @default.
• W2013150218 countsByYear W20131502182019 @default.
• W2013150218 countsByYear W20131502182020 @default.
• W2013150218 countsByYear W20131502182021 @default.
• W2013150218 countsByYear W20131502182022 @default.
• W2013150218 countsByYear W20131502182023 @default.
• W2013150218 crossrefType "journal-article" @default.
• W2013150218 hasAuthorship W2013150218A5007536978 @default.
• W2013150218 hasAuthorship W2013150218A5008583952 @default.
• W2013150218 hasAuthorship W2013150218A5013716423 @default.
• W2013150218 hasAuthorship W2013150218A5014165482 @default.
• W2013150218 hasAuthorship W2013150218A5018360276 @default.
• W2013150218 hasAuthorship W2013150218A5020435407 @default.
• W2013150218 hasAuthorship W2013150218A5026868070 @default.
• W2013150218 hasAuthorship W2013150218A5027485003 @default.
• W2013150218 hasAuthorship W2013150218A5041567500 @default.
• W2013150218 hasAuthorship W2013150218A5063804577 @default.
• W2013150218 hasAuthorship W2013150218A5070019673 @default.
• W2013150218 hasConcept C114373084 @default.
• W2013150218 hasConcept C116073593 @default.
• W2013150218 hasConcept C118792377 @default.
• W2013150218 hasConcept C161790260 @default.
• W2013150218 hasConcept C170493617 @default.
• W2013150218 hasConcept C178910836 @default.
• W2013150218 hasConcept C185592680 @default.
• W2013150218 hasConcept C193042331 @default.
• W2013150218 hasConcept C202751555 @default.
• W2013150218 hasConcept C2776568683 @default.
• W2013150218 hasConcept C2776991684 @default.
• W2013150218 hasConcept C2777682936 @default.
• W2013150218 hasConcept C2778938600 @default.
• W2013150218 hasConcept C2779321679 @default.
• W2013150218 hasConcept C55493867 @default.
• W2013150218 hasConcept C67847695 @default.
• W2013150218 hasConcept C67907053 @default.
• W2013150218 hasConcept C71240020 @default.
• W2013150218 hasConceptScore W2013150218C114373084 @default.
• W2013150218 hasConceptScore W2013150218C116073593 @default.
• W2013150218 hasConceptScore W2013150218C118792377 @default.
• W2013150218 hasConceptScore W2013150218C161790260 @default.
• W2013150218 hasConceptScore W2013150218C170493617 @default.
• W2013150218 hasConceptScore W2013150218C178910836 @default.
• W2013150218 hasConceptScore W2013150218C185592680 @default.
• W2013150218 hasConceptScore W2013150218C193042331 @default.
• W2013150218 hasConceptScore W2013150218C202751555 @default.
• W2013150218 hasConceptScore W2013150218C2776568683 @default.
• W2013150218 hasConceptScore W2013150218C2776991684 @default.
• W2013150218 hasConceptScore W2013150218C2777682936 @default.
• W2013150218 hasConceptScore W2013150218C2778938600 @default.
• W2013150218 hasConceptScore W2013150218C2779321679 @default.
• W2013150218 hasConceptScore W2013150218C55493867 @default.

• next